Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria
Status:
Completed
Trial end date:
2017-02-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of imatinib in combination
with dihydroartemisinin plus piperaquine in the treatment uncomplicated P. falciparum malaria
in adult male patients.
Phase:
Phase 1
Details
Lead Sponsor:
HuLow
Collaborators:
Hue University Purdue University Università degli Studi di Sassari University of Turin, Italy